On 4 July 2025, the EC fined Alchem and its subsidiary EUR 489,000 for their role in a long-running cartel concerning the active pharmaceutical ingredient SNBB, used in the production of Buscopan and its generics. This marks...more
7/23/2025
/ Antitrust Violations ,
Cartels ,
Competition ,
Drug Pricing ,
Enforcement Actions ,
EU ,
European Commission ,
Healthcare ,
Life Sciences ,
Penalties ,
Pharmaceutical Industry ,
Prescription Drugs
2024 saw a significant increase in overall global fines for antitrust enforcement, with total penalties for the jurisdictions surveyed in our report at USD6.7 billion, over double that of 2023 (USD2.9bn) and substantially...more
3/19/2025
/ Abuse of Dominance ,
Antitrust Provisions ,
Antitrust Violations ,
Artificial Intelligence ,
Asia Pacific ,
Big Tech ,
Cartels ,
Competition ,
Damages ,
Digital Assets ,
Digital Markets Strategy ,
Dispute Resolution ,
Enforcement Actions ,
EU ,
European Commission ,
Fines ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
South Africa ,
Sustainability ,
Technology Sector ,
UK ,
United States
Sanctions for procedural merger control infringements in 2024 did not meet the lofty heights of previous years. But merging parties should not be complacent. The number of infringement decisions increased. The U.S. and China...more
On September 20, 2019, the Supreme Court of Canada (“SCC”) issued a landmark antitrust class action decision in Pioneer Corp. v Godfrey which clarified several procedural questions relating to class actions.
Notably, the...more